The primary mechanisms underlying MASLD are closely linked to the dysregulation of glucose and lipid metabolism, encompassing insulin resistance, lipid accumulation, inflammatory responses, oxidative stress, and other related pathological processes (6, 7). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.